Literature DB >> 7718019

Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects.

T P Leren1, K Solberg, O K Rødningen, S Tonstad, L Ose.   

Abstract

DNA from 20 unrelated familial hypercholesterolemia (FH) subjects were studied by analysis of single-strand conformation polymorphisms (SSCP) for mutations in exon 3 of the low density lipoprotein (LDL) receptor gene. Four different SSCP patterns were observed. The underlying mutations were characterized by DNA sequencing. One pattern represented the wild-type sequence. Another pattern represented a C-->G mutation (FH-Svartor) that changes codon 78 into the amber stop codon. The two other patterns represented heterozygosity and homozygosity, respectively, for a G-->A splice donor mutation (FH-Elverum) in intron 3. Based upon two PCR-based assays, the frequencies of FH-Svartor and FH-Elverum among 267 unrelated FH subjects, were 8% and 25%, respectively. FH Svartor was located on a chromosome with haplotype 3 in all five families where haplotype analysis were performed. FH Elverum was located on haplotype 2 in 16 out of 20 families. The two mutations must be considered founder mutations in the Norwegian population, and their existence will be clinically useful in diagnosing FH. The presence of two founder mutations together with previously published data on the prevalence of FH in Norway, indicate that FH may be a more common disease in Norway than previously thought.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7718019     DOI: 10.1016/0021-9150(94)90091-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Identification of a common low density lipoprotein receptor mutation (R329X) in the south of England: complete linkage disequilibrium with an allele of microsatellite D19S394.

Authors:  I N Day; L Haddad; S D O'Dell; L B Day; R A Whittall; S E Humphries
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

2.  Software and database for the analysis of mutations in the human LDL receptor gene.

Authors:  M Varret; J P Rabès; G Collod-Béroud; C Junien; C Boileau; C Béroud
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

3.  Low dose colestipol in adolescents with familial hypercholesterolaemia.

Authors:  S Tonstad; M Sivertsen; L Aksnes; L Ose
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

4.  Molecular characterization of minor gene rearrangements in Finnish patients with heterozygous familial hypercholesterolemia: identification of two common missense mutations (Gly823-->Asp and Leu380-->His) and eight rare mutations of the LDL receptor gene.

Authors:  U M Koivisto; J S Viikari; K Kontula
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

5.  Mutation scanning by meltMADGE: validations using BRCA1 and LDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general population.

Authors:  Khalid K Alharbi; Mohammed A Aldahmesh; Emmanuel Spanakis; Lema Haddad; Roslyn A Whittall; Xiao-he Chen; Hamid Rassoulian; Matt J Smith; Julie Sillibourne; Nicola J Ball; Nikki J Graham; Patricia J Briggs; Iain A Simpson; David I W Phillips; Deborah A Lawlor; Shu Ye; Stephen E Humphries; Cyrus Cooper; George Davey Smith; Shah Ebrahim; Diana M Eccles; Ian N M Day
Journal:  Genome Res       Date:  2005-07       Impact factor: 9.043

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.